// App-Quantinova.ai

TP1210 : Clinical and immunological changes after 1‐year treatment with a tyrosine‐adsorbed mite allergoid: D. Pteronyssinus 50% + D. Farinae 50%

Researchers

Presenter

  • De La Roca Pinzon F

Principal Investigators

  • Justicia J L

  • Ribo P

  • Boronat A

  • Muoz-Cano R

  • Gelis S

  • Valero A

Medical Centers

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Allergy Therapeutics Ltd, Worthing, United Kingdom

Locations

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Allergic rhinitis

  • Asthma

Biomarkers

  • Immunoglobulin E

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved